If your cancer treatment has failed — it doesn’t mean you’ve run out of hope.

In this deeply personal message, Dr. Dino Prato, founder of Envita Medical Centers, shares what happens when patients hit the end of the conventional oncology road. Many are told to go home, that no more can be done. But at Envita, we’ve helped thousands find personalized, precision-guided paths forward.

📊 In a 2024 study, our care model showed:

• 35x better clinical outcomes in late-stage cancer*

• 43x better quality of life*

• 95x fewer side effects, using advanced targeting and integrative support*
(*see outcomes disclaimer below)

🎯 What You’ll Learn:

• Why most patients we see were given the wrong chemo or integrative agents
• How precision testing (genomics, transcriptomics, immune profiling, spatial biology) opens new options
• Why mapping over 1,000 unique biomarkers can reveal treatments others miss
• Real-world case: A patient sent home from a major hospital entered remission with targeted care
• What you can do right now to stop the guesswork and start a new plan
• If you’re standing at a crossroads — unsure, exhausted, or afraid — you don’t have to do this alone. We’re here to guide you through next steps.

“You’re not out of options. You just haven’t been mapped correctly yet.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493